BioScrip Inc  

(Public, NASDAQ:BIOS)   Watch this stock  
Find more results for BIOS
3.57
-0.06 (-1.65%)
After Hours: 3.57 0.00 (0.00%)
Jul 1, 4:42PM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 3.50 - 3.73
52 week 3.36 - 8.75
Open 3.65
Vol / Avg. 685,926.00/1.13M
Mkt cap 247.12M
P/E     -
Div/yield     -
EPS -1.98
Shares 68.65M
Beta 0.59
Inst. own 95%
Aug 3, 2015
Q2 2015 BioScrip Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
May 11, 2015
BioScrip Inc Annual Shareholders Meeting
May 8, 2015
Q1 2015 BioScrip Inc Earnings Call - Webcast
May 7, 2015
Q1 2015 BioScrip Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin -6.08% -14.57%
Operating margin -1.84% -9.50%
EBITD margin - -3.51%
Return on average assets -7.64% -16.28%
Return on average equity -33.38% -50.19%
Employees 1,955 -
CDP Score - -

Address

100 Clearbrook Rd
ELMSFORD, NY 10523-1116
United States - Map
+1-914-4601600 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

BioScrip, Inc. is engaged in providing infusion and home care management solutions. The Company partners with physicians, hospital systems, skilled nursing facilities, healthcare payers and pharmaceutical manufacturers to provide patients access to post-acute care services. Its segments include Infusion Services and Pharmacy Benefit Management (PBM) Services. Its Infusion Services segment provides services consisting of home infusion therapy, respiratory therapy and the provision of durable medical equipment, products and services. Its PBM Services segment consists of integrated PBM services, which primarily consists of discount card programs that provide alternative for individuals who may be uninsured, underinsured or may have restrictive coverage that disallows reimbursement for certain medications. It provides products, services and condition-specific clinical management programs for health conditions, such as gastrointestinal abnormalities, infectious diseases, and others.

Officers and directors

Myron Z. Holubiak Independent Chairman of the Board
Age: 68
Bio & Compensation  - Reuters
Richard M. Smith President, Chief Executive Officer, Director
Age: 55
Bio & Compensation  - Reuters
Jeffrey M. Kreger Chief Financial Officer, Senior Vice President, Treasurer
Age: 47
Bio & Compensation  - Reuters
Thomas F. Pettit Chief Operating Officer, Senior Vice President
Age: 46
Bio & Compensation  - Reuters
Vito Ponzio Jr. Senior Vice President, Chief Administrative Officer
Age: 60
Bio & Compensation  - Reuters
Brian Stiver Senior Vice President of Sales and Marketing
Age: 52
Bio & Compensation  - Reuters
Donna Trujillo Senior Vice President of Human Resources
Age: 52
Bio & Compensation  - Reuters
Karen Cain Senior Vice President, Chief Strategy and Transformation Officer
Age: 60
Bio & Compensation  - Reuters
David Evans Senior Vice President- Strategic Operations And Reimbursement
Age: 51
Bio & Compensation  - Reuters
C Britt Jeffcoat Chief Accounting Officer, Vice President, Controller
Bio & Compensation  - Reuters